A recipe for patent reform: Australian Government releases its response to Productivity Commission’s Final Report on IP Arrangements in Australia
Late last week, the Australian Government published its much-anticipated response to the Productivity Commission’s Inquiry into IP Arrangements in Australia. The response follows the Commission’s Final Report, which was...
Late last week, the Australian Government published its much-anticipated response to the Productivity Commission’s Inquiry into IP Arrangements in...
Read More
Second Medical Use Claims in Australia
The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein a known substance is to be used in a novel...
The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein...
Read More
Trans-Pacific Partnership Agreement Announced
Last night, finalisation of the 12-country Trans-Pacific Partnership (TPP) Agreement between Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the US and Vietnam was announced...
Last night, finalisation of the 12-country Trans-Pacific Partnership (TPP) Agreement between Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico,...
Read More
High Court Dismisses AstraZeneca Appeal
In our recent article of 26 June 2015 we reported on the High Court of Australia hearing on 13 and 14 May 2015 of the Appeal in the rosuvastatin...
In our recent article of 26 June 2015 we reported on the High Court of Australia hearing on 13...
Read More
High Court Considers Inventive Step in Australia
Last month, on 13 and 14 May 2015, the High Court of Australia heard the Appeal in the rosuvastatin case from the Full Federal Court decision (AstraZeneca AB v...
Last month, on 13 and 14 May 2015, the High Court of Australia heard the Appeal in the rosuvastatin...
Read More
Pharmaceutical Patents Review Recommends Restriction of PTEs/SPCs
In our news alert of 21 November 2012 we drew attention to the Review of Pharmaceutical Patents which was announced by the Australian Government and we raised concerns about...
In our news alert of 21 November 2012 we drew attention to the Review of Pharmaceutical Patents which was...
Read More

Contact our Expert Team

Contact Us